Jul 8, 2024, 12:29
Jennifer Buell: NCI Announces Availability of Botensilimab for Clinical Development
Jennifer Buell, President and Chief Executive Officer of MiNK Therapeutics, shared on X:
“NCI Announces Availability of Botensilimab for Clinical Development
Botensilimab is available through the NCI CTEP program in collaboration with Agenus. Strong LOIs for clinical studies are being evaluated.”
Read further.
Source: Jennifer Buell/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14